Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...
In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...
Infants at highest risk of herpes simplex virus disease who should start immediate empiric aciclovir
The third British Paediatric Surveillance Unit (BPSU) survey of herpes simplex virus (HSV) infection in infants presenting before 90 days of age, reported in this edition of Archives, informs us that ...
Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
Wuppertal, Germany, February 26, 2026 - Aicuris Anti-infective Cures AG (“Aicuris”) today announced that it has entered into a definitive ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Get overwhelmed by cute aggression when you see a baby? Here's why you need to control yourself from kissing them all over!
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Rick Rieder says long-term Treasurys aren't as safe as some investors believe ...
Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...
4d
Survey finds majority of older Canadians with chronic illnesses unaware of increased shingles risk
CNW/ - In Canada, shingles affects an estimated 130,000 individuals each year and approximately 1 in 3 adults will experience ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results